Table 2.
Participants meeting optimal-care goals: cardiovascular risk parameters, medication use, and monthly cost at baseline and 1 year
| Baseline |
P value | Year 1 |
P value | |||
|---|---|---|---|---|---|---|
| ILI | DSE | ILI | DSE | |||
| n (% of total cohort) | 269 (11) | 239 (10) | 0.93 | 517 (24) | 359 (16) | <0.0001 |
| Diabetes | ||||||
| A1C (%) | 6.3 ± 0.4 | 6.3 ± 0.5 | 0.92 | 6.1 ± 0.5 | 6.3 ± 0.4 | <0.0001 |
| Number of prescribed medications | 1.3 ± 0.9 | 1.4 ± 0.9 | 0.28 | 1.1 ± 0.5 | 1.5 ± 0.9 | <0.001 |
| Monthly cost ($) | 74 (33) | 86 (33) | 0.13 | 70 (33) | 101 (55) | <0.001 |
| Hypertension | ||||||
| Systolic blood pressure (mmHg) | 114 ± 10 | 115 ± 10 | 0.68 | 112 ± 10 | 114 ± 10 | <0.0001 |
| Diastolic blood pressure (mmHg) | 65 ± 8 | 65 ± 8 | 0.90 | 63 ± 8 | 64 ± 8 | 0.20 |
| Number of prescribed medications | 1.4 ± 1.1 | 1.3 ± 1.1 | 0.34 | 1.4 ± 1.1 | 1.5 ± 1.1 | 0.05 |
| Monthly cost ($) | 40 (24) | 35 (24) | 0.39 | 37 (24) | 40 (24) | 0.08 |
| Hyperlipidemia | ||||||
| LDL cholesterol (mg/dl) | 80 ± 15 | 81 ± 14 | 0.49 | 80 ± 15 | 79 ± 14 | 0.84 |
| HDL cholesterol (mg/dl) | 43 ± 12 | 43 ± 12 | 0.99 | 47 ± 13 | 45 ± 12 | <0.0001 |
| Triglycerides (mg/dl) | 183 ± 116 | 180 ± 118 | 0.40 | 152 ± 93 | 166 ± 95 | <0.0001 |
| Non-HDL cholesterol (mg/dl) | 114 ± 24 | 117 ± 24 | 0.26 | 107 ± 23 | 110 ± 21 | 0.03 |
| Number of prescribed medications | 1.4 ± 1.1 | 1.3 ± 1.1 | 0.48 | 1.4 ± 1.1 | 1.5 ± 1.1 | 0.009 |
| Monthly cost ($) | 48 (65) | 52 (65) | 0.62 | 47 (65) | 54 (65) | 0.008 |
| Total medications | ||||||
| Number of prescribed medications | 3.4 ± 1.8 | 3.5 ± 1.7 | 0.86 | 3.2 ± 1.7 | 3.8 ± 1.6 | <0.001 |
| Monthly cost ($) | 163 (139) | 172 (142) | 0.86 | 154 (128) | 194 (177) | <0.001 |
Data are mean ± SD or frequency (%) and monthly cost data are mean (median), unless otherwise specified. Participants at optimal care defined as participants with A1C <7%, blood pressure <130/80 mmHg, and LDL cholesterol <100 mg/dl as measured at the applicable study visit.